Cargando…

Potential Toxicity Risk Assessment and Priority Control Strategy for PAHs Metabolism and Transformation Behaviors in the Environment

In this study, 16 PAHs were selected as the priority control pollutants to summarize their environmental metabolism and transformation processes, including photolysis, plant degradation, bacterial degradation, fungal degradation, microalgae degradation, and human metabolic transformation. Meanwhile,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Lei, Zhou, Mengying, Zhao, Yuanyuan, Yang, Jiawen, Pu, Qikun, Yang, Hao, Wu, Yang, Lyu, Cong, Li, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9517862/
https://www.ncbi.nlm.nih.gov/pubmed/36078713
http://dx.doi.org/10.3390/ijerph191710972
_version_ 1784799044337401856
author Zhao, Lei
Zhou, Mengying
Zhao, Yuanyuan
Yang, Jiawen
Pu, Qikun
Yang, Hao
Wu, Yang
Lyu, Cong
Li, Yu
author_facet Zhao, Lei
Zhou, Mengying
Zhao, Yuanyuan
Yang, Jiawen
Pu, Qikun
Yang, Hao
Wu, Yang
Lyu, Cong
Li, Yu
author_sort Zhao, Lei
collection PubMed
description In this study, 16 PAHs were selected as the priority control pollutants to summarize their environmental metabolism and transformation processes, including photolysis, plant degradation, bacterial degradation, fungal degradation, microalgae degradation, and human metabolic transformation. Meanwhile, a total of 473 PAHs by-products generated during their transformation and degradation in different environmental media were considered. Then, a comprehensive system was established for evaluating the PAHs by-products’ neurotoxicity, immunotoxicity, phytotoxicity, developmental toxicity, genotoxicity, carcinogenicity, and endocrine-disrupting effect through molecular docking, molecular dynamics simulation, 3D-QSAR model, TOPKAT method, and VEGA platform. Finally, the potential environmental risk (phytotoxicity) and human health risks (neurotoxicity, immunotoxicity, genotoxicity, carcinogenicity, developmental toxicity, and endocrine-disrupting toxicity) during PAHs metabolism and transformation were comprehensively evaluated. Among the 473 PAH’s metabolized and transformed products, all PAHs by-products excluding ACY, CHR, and DahA had higher neurotoxicity, 152 PAHs by-products had higher immunotoxicity, and 222 PAHs by-products had higher phytotoxicity than their precursors during biological metabolism and environmental transformation. Based on the TOPKAT model, 152 PAH by-products possessed potential developmental toxicity, and 138 PAH by-products had higher genotoxicity than their precursors. VEGA predicted that 247 kinds of PAH derivatives had carcinogenic activity, and only the natural transformation products of ACY did not have carcinogenicity. In addition to ACY, 15 PAHs produced 123 endocrine-disrupting substances during metabolism and transformation. Finally, the potential environmental and human health risks of PAHs metabolism and transformation products were evaluated using metabolic and transformation pathway probability and degree of toxic risk as indicators. Accordingly, the priority control strategy for PAHs was constructed based on the risk entropy method by screening the priority control pathways. This paper assesses the potential human health and environmental risks of PAHs in different environmental media with the help of models and toxicological modules for the toxicity prediction of PAHs by-products, and thus designs a risk priority control evaluation system for PAHs.
format Online
Article
Text
id pubmed-9517862
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95178622022-09-29 Potential Toxicity Risk Assessment and Priority Control Strategy for PAHs Metabolism and Transformation Behaviors in the Environment Zhao, Lei Zhou, Mengying Zhao, Yuanyuan Yang, Jiawen Pu, Qikun Yang, Hao Wu, Yang Lyu, Cong Li, Yu Int J Environ Res Public Health Article In this study, 16 PAHs were selected as the priority control pollutants to summarize their environmental metabolism and transformation processes, including photolysis, plant degradation, bacterial degradation, fungal degradation, microalgae degradation, and human metabolic transformation. Meanwhile, a total of 473 PAHs by-products generated during their transformation and degradation in different environmental media were considered. Then, a comprehensive system was established for evaluating the PAHs by-products’ neurotoxicity, immunotoxicity, phytotoxicity, developmental toxicity, genotoxicity, carcinogenicity, and endocrine-disrupting effect through molecular docking, molecular dynamics simulation, 3D-QSAR model, TOPKAT method, and VEGA platform. Finally, the potential environmental risk (phytotoxicity) and human health risks (neurotoxicity, immunotoxicity, genotoxicity, carcinogenicity, developmental toxicity, and endocrine-disrupting toxicity) during PAHs metabolism and transformation were comprehensively evaluated. Among the 473 PAH’s metabolized and transformed products, all PAHs by-products excluding ACY, CHR, and DahA had higher neurotoxicity, 152 PAHs by-products had higher immunotoxicity, and 222 PAHs by-products had higher phytotoxicity than their precursors during biological metabolism and environmental transformation. Based on the TOPKAT model, 152 PAH by-products possessed potential developmental toxicity, and 138 PAH by-products had higher genotoxicity than their precursors. VEGA predicted that 247 kinds of PAH derivatives had carcinogenic activity, and only the natural transformation products of ACY did not have carcinogenicity. In addition to ACY, 15 PAHs produced 123 endocrine-disrupting substances during metabolism and transformation. Finally, the potential environmental and human health risks of PAHs metabolism and transformation products were evaluated using metabolic and transformation pathway probability and degree of toxic risk as indicators. Accordingly, the priority control strategy for PAHs was constructed based on the risk entropy method by screening the priority control pathways. This paper assesses the potential human health and environmental risks of PAHs in different environmental media with the help of models and toxicological modules for the toxicity prediction of PAHs by-products, and thus designs a risk priority control evaluation system for PAHs. MDPI 2022-09-02 /pmc/articles/PMC9517862/ /pubmed/36078713 http://dx.doi.org/10.3390/ijerph191710972 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Zhao, Lei
Zhou, Mengying
Zhao, Yuanyuan
Yang, Jiawen
Pu, Qikun
Yang, Hao
Wu, Yang
Lyu, Cong
Li, Yu
Potential Toxicity Risk Assessment and Priority Control Strategy for PAHs Metabolism and Transformation Behaviors in the Environment
title Potential Toxicity Risk Assessment and Priority Control Strategy for PAHs Metabolism and Transformation Behaviors in the Environment
title_full Potential Toxicity Risk Assessment and Priority Control Strategy for PAHs Metabolism and Transformation Behaviors in the Environment
title_fullStr Potential Toxicity Risk Assessment and Priority Control Strategy for PAHs Metabolism and Transformation Behaviors in the Environment
title_full_unstemmed Potential Toxicity Risk Assessment and Priority Control Strategy for PAHs Metabolism and Transformation Behaviors in the Environment
title_short Potential Toxicity Risk Assessment and Priority Control Strategy for PAHs Metabolism and Transformation Behaviors in the Environment
title_sort potential toxicity risk assessment and priority control strategy for pahs metabolism and transformation behaviors in the environment
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9517862/
https://www.ncbi.nlm.nih.gov/pubmed/36078713
http://dx.doi.org/10.3390/ijerph191710972
work_keys_str_mv AT zhaolei potentialtoxicityriskassessmentandprioritycontrolstrategyforpahsmetabolismandtransformationbehaviorsintheenvironment
AT zhoumengying potentialtoxicityriskassessmentandprioritycontrolstrategyforpahsmetabolismandtransformationbehaviorsintheenvironment
AT zhaoyuanyuan potentialtoxicityriskassessmentandprioritycontrolstrategyforpahsmetabolismandtransformationbehaviorsintheenvironment
AT yangjiawen potentialtoxicityriskassessmentandprioritycontrolstrategyforpahsmetabolismandtransformationbehaviorsintheenvironment
AT puqikun potentialtoxicityriskassessmentandprioritycontrolstrategyforpahsmetabolismandtransformationbehaviorsintheenvironment
AT yanghao potentialtoxicityriskassessmentandprioritycontrolstrategyforpahsmetabolismandtransformationbehaviorsintheenvironment
AT wuyang potentialtoxicityriskassessmentandprioritycontrolstrategyforpahsmetabolismandtransformationbehaviorsintheenvironment
AT lyucong potentialtoxicityriskassessmentandprioritycontrolstrategyforpahsmetabolismandtransformationbehaviorsintheenvironment
AT liyu potentialtoxicityriskassessmentandprioritycontrolstrategyforpahsmetabolismandtransformationbehaviorsintheenvironment